Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Asset Writedowns and Impairment (2021 - 2025)

Biote has reported Asset Writedowns and Impairment over the past 5 years, most recently at $437000.0 for Q4 2025.

  • Quarterly results put Asset Writedowns and Impairment at $437000.0 for Q4 2025, up 207.11% from a year ago — trailing twelve months through Dec 2025 was $2.0 million (up 302.19% YoY), and the annual figure for FY2025 was $2.0 million, up 302.19%.
  • Asset Writedowns and Impairment for Q4 2025 was $437000.0 at Biote, down from $624000.0 in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for BTMD hit a ceiling of $773000.0 in Q1 2025 and a floor of -$798000.0 in Q3 2023.
  • Median Asset Writedowns and Impairment over the past 5 years was $71500.0 (2024), compared with a mean of $151444.4.
  • Biggest five-year swings in Asset Writedowns and Impairment: surged 2353.33% in 2023 and later tumbled 6900.0% in 2024.
  • Biote's Asset Writedowns and Impairment stood at $291000.0 in 2021, then plummeted by 180.76% to -$235000.0 in 2022, then surged by 102.55% to $6000.0 in 2023, then tumbled by 6900.0% to -$408000.0 in 2024, then skyrocketed by 207.11% to $437000.0 in 2025.
  • The last three reported values for Asset Writedowns and Impairment were $437000.0 (Q4 2025), $624000.0 (Q3 2025), and $189000.0 (Q2 2025) per Business Quant data.